© Reuters. FILE PHOTO: GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration/File Photo
(Reuters) – British drugmaker GSK said on Wednesday it had raised 978 million pounds ($1.24 billion) from a discounted stake sale in Haleon, cutting its shareholding to 4.2% in the world’s largest standalone consumer healthcare firm.
GSK sold around 300 million shares in its spun-off unit at a price of 326 pence per share.
($1 = 0.7918 pounds)
In 2024, over 12.2 billion choices contracts traded arms, representing an enormous shift towards extra subtle funding methods amongst particular...
This text was written byComply withDaniel is an avid and lively skilled investor. He runs Crude Worth Insights, a...
We do issues a bit in another way at Inventory Gumshoe — we love our free readers, we don’t provide...
Flip your returns and extra stock right into a strategic benefit. Learn the way our platform helps manufacturers, retailers, and...
The Jefferies Monetary Group Inc. headquarters in New York, US, on Monday, Oct. 20, 2025. Michael Nagle | Bloomberg |...
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.
